2 months The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics Zacks X
2 months Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily X
2 months Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? Investor's Business Daily X
2 months These Stocks Moved the Most Today: Micron, Tesla, Palantir, Quantum Computing, Lamb Weston, Accenture, Vertex, Darden, and More Yahoo Finance X
2 months Vertex Dives 11% On A ‘Worst-Case Scenario’ For Its Non-Opioid Pain Drug Investor's Business Daily X
2 months Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily X
2 months Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks X
2 months Health AI startup Suki deliver patient summary, Q&A features for clinicians with Google Cloud CNBC X
2 months Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks X
3 months Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock Yahoo Finance X
3 months Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know Zacks X
3 months Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript) Seeking Alpha X
3 months Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks X
4 months Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It Seeking Alpha X
4 months Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha X
4 months Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms Investor's Business Daily X
Stock Market News